ПРОФИЛАКТИКА ВЕНОЗНЫХ ТРОМБОЭМБОЛИЧЕСКИХ ОСЛОЖНЕНИЙ В ТЕРАПЕВТИЧЕСКОЙ ПРАКТИКЕ
https://doi.org/10.21518/2079-701X-2017-7-43-47
Аннотация
Венозные тромбоэмболические осложнения остаются значимой причиной смертности и инвалидизации у госпитализированных больных как в хирургической, так и в терапевтической практике во всем мире, несмотря на то, что медикаментозные и механические способы профилактики известны уже несколько десятилетий.
Об авторах
Н. А. Новикова
Первый Московский государственный медицинский университет им. И.М. Сеченова Минздрава России
Россия
д.м.н., профессор
Россия
д.м.н., профессор
А. С. Шилова
Первый Московский государственный медицинский университет им. И.М. Сеченова Минздрава России
Россия
Россия
Список литературы
1. Bergmann JF, Cohen AT, Tapson VF, Goldhaber SZ, Kakkar AK, Deslandes B et al. Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey. Thromb Haemost, 2010, 103(4): 736-48.
2. Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet, 2008, 371(9610): 387-94.
3. Dentali F, Donadini M, Gianni M, Bertolini A, Squizzato A, Venco A et al. Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism. Thromb Res, 2009, 124(3): 256-8.
4. Karwinski B, Svendsen E. Comparison of clinical and postmortem diagnosis of pulmonary embolism. J Clin Pathol, 1989, 42(2): 135-9.
5. Sweetland S, Green J, Liu B, Berrington de Gonzalez A, Canonico M, Reeves G et al. Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. BMJ, 2009, 339: b4583.
6. Goldhaber SZ, Ridker PM. Thrombosis and Thromboembolism. New York, NY: Marcel Dekker, Inc, 2002.
7. Geerts WH, Heit JA, Clagett GP et al. Prevention of venous thromboembolism. Chest, 2001, 119: 132S–175S.
8. Goldhaber SZ, Savage DD, Garrison RJ, Castelli WP, Kannel WB, McNamara PM et al. Risk factors for pulmonary embolism. The Framingham Study. Am J Med, 1983, 74(6): 1023-8.
9. Kucher N, Koo S, Quiroz R et al. Electronic Alerts to Prevent Venous Thromboembolism among Hospitalized Patients. N Engl J Med, 2005, 352: 969-977.
10. Alikhan R, Cohen AT. Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction). Cochrane Database of Systematic Reviews, 2009.
11. Hirsh J, Warkentin TE, Shaughnessy SG, Anand SS, Halperin JL, Raschke R et al. Heparin and lowmolecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest, 2001, 119(1 Suppl): 64S-94S.
12. Boneu B. Low molecular weight heparin therapy: is monitoring needed? Thromb Haemost, 1994, 72(3): 330-4.
13. Dunn AS, Brenner A, Halm EA. The magnitude of an iatrogenic disorder: a systematic review of the incidence of venous thromboembolism for general medical inpatients. Thromb Haemost, 2006, 95(5): 758-62.
14. Vessey M, Mant D, Smith A, Yeates D. Oral contraceptives and venous thromboembolism: findings in a large prospective study. Br Med J (Clin Res Ed), 1986, 292(6519): 526.
15. Antiplatelet Trialists’ Collaboration. Collaborative overview of randomised trials of antiplatelet therapy–III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists’ Collaboration. BMJ, 1994, 308(6923): 235-46.
16. Wein L, Wein S, Haas SJ, Shaw J, Krum H. Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials. Arch Intern Med, 2007, 167(14): 1476-86.
17. Alikhan R, Cohen AT. Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction). Cochrane Database of Systematic Reviews, 2009.
18. Ginzburg E, Cohn SM, Lopez J, Jackowski J, Brown M, Hameed SM et al. Randomized clinical trial of intermittent pneumatic compression and low molecular weight heparin in trauma. Br J Surg, 2003, 90(11): 1338-44.
19. Akl EA, Karmath G, Yosuico V, Kim SY, Barba M, Sperati F, Cook D, Schünemann HJ. Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters. Cochrane Database of Systematic Reviews: Reviews 2007 Issue 3 John Wiley & Sons, Ltd Chichester, UK DOI: 10.1002/14651858.CD006468.pub2 2007.
Рецензия
Для цитирования:
Новикова Н.А., Шилова А.С. ПРОФИЛАКТИКА ВЕНОЗНЫХ ТРОМБОЭМБОЛИЧЕСКИХ ОСЛОЖНЕНИЙ В ТЕРАПЕВТИЧЕСКОЙ ПРАКТИКЕ. Медицинский Совет. 2017;(7):43-47. https://doi.org/10.21518/2079-701X-2017-7-43-47
For citation:
Novikova N.A., Shilova A.S. PREVENTION OF VENOUS THROMBOEMBOLIC COMPLICATIONS IN PRIMARY CARE. Meditsinskiy sovet = Medical Council. 2017;(7):43-47. (In Russ.) https://doi.org/10.21518/2079-701X-2017-7-43-47
Просмотров: 576
Послать статью по эл. почте 